Delivery of testosterone to the brain by intranasal administration: Comparison to intravenous testosterone
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Intranasal (i.n.) administration has emerged as a strategy to deliver therapeutics to the brain. Here, we compared i.n. and intravenous (i.v.) administration for testosterone. About 75% of the i.n. administered testosterone entered the blood. However, whole brain levels of testosterone were about twice as high after i.n. administration as after i.v. administration. About two-thirds of the testosterone entering the brain after i.n. administration did so by direct entry by nasal routes and the remainder indirectly by first entering the blood and then crossing the blood-brain barrier. All brain regions except the frontal cortex had higher levels of testosterone after i.n. administration than after i.v. administration, although the differences among brain regions varied much more for the i.n. route. The olfactory bulb, hypothalamus, striatum, and hippocampus had the highest levels after i.n. administration. The brain uptake pattern suggested a variety of distribution routes likely involving the cerebrospinal fluid, diffusion through brain tissue, and transport through nerve projections. Regional distribution patterns were similar after either i.n. or i.v. administration, suggesting that the dominant factor determining distribution/retention was the same for either route of administration. We conclude that the i.n. administration route delivers testosterone systemically and can target the brain, especially the olfactory bulb, hypothalamus, striatum, and hippocampus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851
Self-citationGhrelin controls hippocampal spine synapse density and memory performance
Diano, S., Farr, S. A., Benoit, S. C., McNay, E. C., da Silva, I., Horvath, B., Gaskin, F. S., Nonaka, N., Jaeger, L. B., Banks, W. A., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1656 · Cited by 828 · cited 1×
“This differs markedly from some peptides, which have a much lower bioavailability after i.n. administration (Kern et al. 1999; Kastin and Akerstrom 2003; Banks et al. 2004; Diano et al. 2006).”
BackgroundSelf-citationEvaluation of assays available to measure free testosterone
Morley, J. E., Patrick, P., & Perry, H. M. (2002) · Metabolism · doi:10.1053/meta.2002.31975 · Cited by 309
Self-citationAndrogens and Women at the Menopause and Beyond
Morley, J. E., & Perry, H. M. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.5.m409 · Cited by 98 · cited 1×
“…of conditions, such as mild cognitive impairment, Alzheimer’s disease, female sexual dysfunction, and age-related neuromus- cular atrophy and stroke (Morley and Perry 2003; Shifren 2004; Cherrier et al. 2005; Haren et al. 2005; Matsumoto 2005; Pan et al. 2005; Beauchet 2006; Fargo et al. 2007).”
BackgroundSelf-citation
Cited by
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route
Patel, S., Chavhan, S., Soni, H., Babbar, A. K., Mathur, R., Mishra, A. K., & Sawant, K. (2011) · Journal of Drug Targeting · doi:10.3109/1061186x.2010.523787 · Cited by 186
“Earlier studies have demonstrated that intranasal administration offers a practical, noninvasive, and an alternative route of administration for rapid drug delivery to brain (Lu et al., 2008; Banks et al., 2009; Khan et al., 2010; Chow et al., 1999).”
BackgroundIntranasal administration of oxytocin: behavioral and clinical effects, a review
Veening, J. G., & Olivier, B. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.012 · Cited by 169
“…insulin-like growth factor-1 (Thorne t al., 2004) and hexarelin (Yu and Kim, 2009), as well as for a ariety of other substances like testosterone (Banks et al., 2009), stradiol (Ohman et al., 1980; Wang et al., 2006), ergoloid mesylate Chen et al., 2008), gastrodin (Wang et al., 2007, 2008),…”
BackgroundThe blood-brain barrier and nasal drug delivery to the central nervous system
Miyake, M. M., & Bleier, B. S. (2015) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2015.29.4149 · Cited by 106
Late-Life Onset Hypogonadism: A Review
Bassil, N., & Morley, J. E. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.02.003 · Cited by 59
“Intranasal testosterone Testosterone is well absorbed after nasal administration.(60) Application of MPP 10”
Self-citation
Metadata
- Authors
- Banks, W. A., Morley, J. E., Niehoff, M. L., & Mattern, C.
- Venue
- Journal of Drug Targeting
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 17
- Issue
- 2
- Pages
- 91-97
- ISSN
- 1026-7158 (ISSN-L)
- 1061-186X
- 1029-2330
- OpenAlex
- W2024792732
- Cited by
- 68
- References
- 5
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Delivery of testosterone to the brain by intranasal administration: Comparison to intravenous testosterone. https://app.cochat.ai/papers/10.1080/10611860802382777
- The paper
- Banks, W. A., Morley, J. E., Niehoff, M. L., & Mattern, C. (2009). Delivery of testosterone to the brain by intranasal administration: Comparison to intravenous testosterone. Journal of Drug Targeting. https://doi.org/10.1080/10611860802382777
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.